XML 37 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2022
Discontinued Operations  
Schedule of contract royalty asset

The following schedule is a rollforward of the OMIDRIA contract royalty asset (in thousands):

OMIDRIA contract royalty asset at December 31, 2021

$

184,570

Royalties earned

(65,439)

Interest on OMIDRIA contract royalty asset

18,634

Remeasurement adjustments

14,457

OMIDRIA contract royalty asset at December 31, 2022

$

152,222

Schedule of net income from discontinued operation

Year Ended December 31, 

    

2022

    

2021

    

2020

(In thousands)

Product sales, net

$

$

110,735

$

73,813

Costs and expenses

30,631

27,496

Gross margin

80,104

46,317

Gain on sale of OMIDRIA

305,648

Milestone income

200,000

Interest on OMIDRIA contract royalty asset

18,634

Remeasurement adjustments

14,457

Other income

 

307

1,035

Income before income tax

233,398

386,787

46,317

Income tax expense (1)

(3,952)

(1,006)

(11,245)

Net income from discontinued operations, net of tax

$

229,446

$

385,781

$

35,072

(1)For further discussion of income tax expense refer to “Note 14 – Income Taxes”.
Schedule of gain on sale of Omidria

The year ended December 31, 2021 included a gain on the sale of OMIDRIA comprised as follows (in thousands):

Cash proceeds

$

125,993

OMIDRIA contract royalty asset

184,570

Gain on sale of OMIDRIA, gross

310,563

Transaction and closing costs

(1,972)

RSUs granted to transferred employees

(1,419)

Prepaid assets and inventory at cost

(1,524)

Gain on sale of OMIDRIA

$

305,648

Schedule of cash flow from discontinued operation

Year Ended December 31, 2022

    

2022

    

2021

    

2020

(In thousands)

Net cash provided by discontinued operations from operating activities

$

44,929

$

56,344

$

25,888

Net cash provided by discontinued operations from investing activities

$

$

125,993

$